We’re proud to share that Lantern has been named to Fast Company’s list of the World’s Most Innovative Companies of 2026, ranking No. 3 in Healthcare.
Fast Company recognized Lantern for “making specialty care such as infusions more accessible and cost effective—and then showing everyone else how it’s done.”
At Lantern, we believe that innovation in healthcare is most meaningful when it makes the care people need higher quality and easier to find. This goal matters both for patients who struggle to identify quality providers and pay for care, and for employers and funds facing unsustainable cost increases.
A few ways we’re innovating to make care better in the moments that matter most:
- Reducing the cost of infusion therapy for employers by 40%+ while making it easier for patients to get quality care at home or close to home
- Building a specialist-first Network of Excellence that prioritizes appropriate care with rates 55%+ lower compared with carriers
- Expanding comprehensive cancer navigation, including expert clinical review and ongoing engagement, while keeping care local whenever possible
- Partnering with organizations like AccessHope to bring NCI-based clinical expertise into the member experience
- Adding new capabilities to identify and engage members earlier in their care journey
This recognition also reflects Lantern’s impact and momentum: today, we support more than 12 million members nationwide, helping employers and funds manage the fastest-growing drivers of healthcare spend while improving access and outcomes for their people.
We’re grateful to everyone across the Lantern ecosystem pushing for and embracing change in the system. And we can’t wait for what’s next.
For making specialty care such as infusions more accessible and cost effective—and then showing everyone else how it’s done.
